PROVE: Retrospective Cefiderocol Chart Review Study (Version1.0 EU)

• Research type

  Research Study

• Full title

  A retrospective chart review study of cefiderocol real world outcomes and safety in the treatment of patients with Gram-negative bacterial infections (GNBI) in the USA and Europe.

• IRAS ID

  297861

• Contact name

  Stefano Verardi

• Contact email

  stefano.verardi@shionogi.eu

• Sponsor organisation

  Shionogi B.V.

• Duration of Study in the UK

  1 years, 9 months, 31 days

• Research summary

  A retrospective patient records review of cefiderocol real world clinical and microbiological outcomes and safety in the treatment of patients with Gram-negative bacterial infections (GNBI) in the USA and Europe.

• REC name

  East Midlands - Nottingham 1 Research Ethics Committee

• REC reference

  21/EM/0143

• Date of REC Opinion

  10 Jun 2021

• REC opinion

  Favourable Opinion